Search

Your search keyword '"Carter, Martyn"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Carter, Martyn" Remove constraint Author: "Carter, Martyn"
40 results on '"Carter, Martyn"'

Search Results

1. Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study

2. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

3. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

4. Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study

5. HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease

6. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

7. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

9. Histo-MRI map study protocol: a prospective cohort study mapping MRI to histology for biomarker validation and prediction of prostate cancer

10. Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumab

12. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581]

13. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

14. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

15. Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn’s disease: long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource

18. HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease

19. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581]

20. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

21. Intussusception of the appendix secondary to endometriosis: a case report

23. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

24. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

25. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

27. The setting up and running of a cross-county out-of-hours gastrointestinal bleed service: a possible blueprint for the future

35. The setting up and running of a cross-county out-of-hours gastrointestinal bleed service: a possible blueprint for the future.

37. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

39. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease.

Catalog

Books, media, physical & digital resources